Clinical Application of New Risk-Based Cancer Screening in Patients With Dermatomyositis
Maderal and Femia discuss dermatomyositis (DM), which is an autoimmune disease that often co-occurs with cancer. While there's a strong link between the two, there's no clear consensus on optimal cancer screening practices for DM patients. DM patients have a higher risk of developing vario...
Gespeichert in:
Veröffentlicht in: | Archives of dermatology (1960) 2024-11, Vol.160 (11), p.1151-1152 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Maderal and Femia discuss dermatomyositis (DM), which is an autoimmune disease that often co-occurs with cancer. While there's a strong link between the two, there's no clear consensus on optimal cancer screening practices for DM patients. DM patients have a higher risk of developing various cancers, including breast, ovarian, colorectal, lung, and nasopharyngeal cancers. The lack of clear guidelines and the need to balance early detection with avoiding unnecessary tests make it difficult to determine the best screening strategies. |
---|---|
ISSN: | 2168-6068 2168-6084 2168-6084 |
DOI: | 10.1001/jamadermatol.2024.3349 |